Search

Search Constraints

You searched for: Author/Creator Lipe, Brea

Search Results

2. A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end‐stage renal disease requiring haemodialysis. (16th May 2016)

4. Bisphosphonates for delivering drugs to bone. (10th April 2021)

5. Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial. Issue 1 (January 2021)

7. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group. Issue 2 (February 2022)

9. Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma. Issue 1 (8th November 2020)

10. Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment. Issue 4 (30th September 2022)